Most Recent
Monsanto faces class action in Australia over Roundup weedkiller
Agricultural giant Monsanto is facing a class action in Australia over the marketing of its Roundup weedkiller, after being hit with a landmark US$ 2 billion verdict in the United States.
Family tries again for cut of Malaysia Airlines class action settlement
The family of an Australian national who was killed aboard Malaysia Airlines flight MH17 is challenging a ruling that blocked it from participating in a recent class action settlement.
Full Court docket stacked with class action appeals
The Full Federal Court is set to hear appeals in four class actions in the August sitting, giving the court a chance to address important issues, including cost-capping in joint class actions and security for costs in unfunded cases. Here, we give you the run-down on each of the upcoming challenges.
Malaysia Airlines settles class action by Australian MH17 families
Malaysia Airlines has reached a settlement with five Australian families whose loved ones were killed when flight MH17 was shot down over eastern Ukraine by a Russian missile five years ago.
Horse vaccine class action gets chance to add sample group member to bring ‘valid’ consumer claim
Noting the relevant three-year limitations provision was "quite unusal", the judge overseeing a consumer class action against horse vaccine manufacturer Zoetis has given the class a chance to add a second applicant to the case, after it was revealed that part of the lead applicant's claim was out of time. 
Zoetis appeals security of costs ruling in horse vaccine class action
Horse vaccine maker Zoetis has appealed a ruling that denied its request for $450,000 as security for costs in an unfunded class action accusing it of failing to warn about the vaccine's side effects.
Judge says no to security for costs in unfunded Zoetis horse vaccine class action
A judge has refused an application by horse vaccine maker Zoetis for $450,000 as security for costs in an unfunded class action alleging misleading claims by the pharmaceutical company, saying while he had the power to make the order sought, the "principled exercise" of his discretion was to reject the bid.